Autoimmune mouse antibodies recognize multiple antigens proposed in human immune-mediated hearing loss

Otology and Neurotology

Volumn 25, Issue 3, 2004, Pages 250-256

  Hefeneider, Steven H ^a,b   McCoy, Sharon L ^a   Hausman, Frances A ^a   Trune, Dennis R ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Autoimmune inner ear disease; Autoimmune mouse; Cardiolipin; Collagen; Heat shock protein; Heparan sulfate proteoglycans; Laminin

Indexed keywords

ANTIGEN; AUTOANTIBODY; AUTOANTIGEN; CARDIOLIPIN; COCHLEA ANTIGEN; COLLAGEN TYPE 2; COLLAGEN TYPE 4; FAS ANTIGEN; HEAT SHOCK PROTEIN 70; LAMININ; PROTEOHEPARAN SULFATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIGEN ANTIBODY REACTION; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEARING LOSS; IMMUNE MEDIATED INJURY; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; COCHLEA; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEARING LOSS; HUMANS; MICE; MICE, INBRED C3H; MICE, INBRED MRL LPR;

EID: 4043140229     PISSN: 15317129     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129492-200405000-00009     Document Type: Article

References (92)

1. Hughes GB, Barna BP, Calabrese LH, et al. Immunologic disorders of the inner ear. In: Bailey BJ, ed. Head Neck Surgery-Otolaryngology. Philadelphia: Lippincott, 1993:1833-41.
2. Magaro M, Zoli A, Altomonte L, et al. Sensorineural hearing loss in rheumatoid arthritis. Clin Exp Rheumatol 1990;8:487-90.
3. Elwany S, Garf AE, Kamel T. Hearing and middle ear function in rheumatoid arthritis. J Rheumatol 1986;13:878-81.
4. Harris JP, Ryan AF. Fundamental immune mechanisms of the brain and inner ear. Otolaryngol Head Neck Surg 1995;112:639-53.
5. Jerger JF, Oliver TA, Chmiel RA, et al. Patterns of auditory abnormality in multiple sclerosis. Audiology 1986;25:193-209.
6. Furst M, Aharonson V, Levine RA, et al. Sound lateralization and interaural discrimination. Effects of brainstem infarcts and multiple sclerosis lesions. Hear Res 2000;143:29-42.
7. Tumiati B, Casoli P, Parmeggiani P. Hearing loss in the Sjögren's syndrome. Ann Intern Med 1997;126:450-3.
8. Barna BP, Hughes GB. Autoimmune inner ear disease - a real entity? Clin Lab Med 1997;17:581-94.
9. Sperling NM, Tehrani K, Liebling A, et al. Aural symptoms and hearing loss in patients with lupus. Otolaryngol Head Neck Surg 1998;118:762-5.
10. Andonopoulos AP, Naxakis S, Goumas P, et al. Sensorineural hearing disorders in systemic lupus erythematosus. A controlled study. Clin Exp Rheumatol 1995;13:137-41.
11. Naarendorp M, Spiera H. Sudden sensorineural hearing loss in patients with systemic lupus erythematosus or lupus-like syndromes and antiphospholipid antibodies. J Rheumatol 1998;25:589-92.
12. Hongjun X, Jibao W. Inner ear autoantibodies in patients with systemic lupus erythematosus. Proc Sendai Symp 1995;5:55-7.
13. Kanzaki J, O-Uchi T. Circulating immune complexes in steroid-responsive sensorineural hearing loss and the long-term observation. Acta Otolaryngol 1983;Suppl 393:77-84.
14. Veldman JE. Immunology of hearing: experiments of nature. Am J Otol 1989;10:183-7.
15. Veldman JE, Roord JJ, O'Connor AF, et al. Autoimmunity and inner ear disorders: an immune complex mediated sensorineural hearing loss. Laryngoscope 1984;94:501-7.
16. Brookes GB. Immune complex-associated deafness: preliminary communication. J Royal Soc Med 1985;78:47-55.
17. Shin SO, Billings PB, Keithley EM, et al. Comparison of anti-heat shock protein 70 (anti-hsp70) and anti-68-kDa inner ear protein in the sera of patients with Ménière's disease. Laryngoscope 1997;107:222-7.
18. Ruckenstein MJ, Prasthoffer A, Bigelow DC, et al. Immunologic and serologic testing in patients with Ménière's disease. Otol Neurotol 2002;23:517-21.
19. Gottschlich S, Billings PB, Keithley EM, et al. Assessment of serum antibodies in patients with rapidly progressive sensorineural hearing loss and Ménière's disease. Laryngoscope 1995;105:1347-52.
20. Hughes GB, Kinney SE, Barna BP, et al. Autoimmune reactivity in Ménière's disease: a preliminary report. Laryngoscope 1983;93:410-7.
21. Brookes GB. Circulating immune complexes in Ménière's disease. Arch Otolaryngol Head Neck Surg 1986;112:536-40.
22. Hsu L, Zhu X-N, Zhao Y-S. Immunoglobulin E and circulating immune complexes in endolymphatic hydrops. Ann Otol Rhinol Laryngol 1990;99:535-8.
23. Derebery MJ, Rao VS, Siglock TJ, et al. Ménière's disease: an immune complex-mediated illness? Laryngoscope 1991;101:225-9.
24. Arnold W, Pfaltz R, Altermatt H-J. Evidence of serum antibodies against inner ear tissues in the blood of patients with certain sensorineural hearing disorders. Acta Otolaryngol 1985;99:437-44.
25. Sismanis A, Wise CM, Johnson GD. Methotrexate management of immune-mediated cochleovestibular disorders. Otolaryngol Head Neck Surg 1997;116:146-52.
26. Mayot D, Béné MC, Dron K, et al. Immunologic alterations in patients with sensorineural hearing disorders. Clin Immunol Immunopathol 1993;68:41-5.
27. Disher MJ, Ramakrishnan A, Nair TS, et al. Human autoantibodies and monoclonal antibody KHRI-3 bind to a phylogenetically conserved inner-ear-supporting cell antigen. Ann NY Acad Sci 1997;830:253-65.
28. Billings PB, Shin SO, Harris JP. Assessing the role of anti-hsp70 in cochlear impairment. Hear Res 1998;126:210-2.
29. Bloch DB, Gutierrez JA, Guerriero V Jr, et al. Recognition of a dominant epitome in bovine heat-shock protein 70 in inner ear disease. Laryngoscope 1999;109:621-5.
30. Yoo TJ, Stuart JM, Kang AH, et al. Type II collagen autoimmunity in otosclerosis and Ménière's disease. Science 1982;217:1153-5.
31. Helfgott SM, Mosciscki RA, San Martin J, et al. Correlation between antibodies to type II collagen and treatment outcome in bilateral progressive sensorineural hearing loss. Lancet 1991;337:387-9.
32. Joliat T, Seyer J, Bernstein J, et al. Antibodies against a 30 kilo-dalton cochlear protein and type II and IX collagens in the serum of patients with inner ear diseases. Ann Otol Rhinol Laryngol 1992;101:1000-6.
33. Cao MY, Dupriez VJ, Rider MH, et al. Myelin protein Po as a potential autoantigen in autoimmune inner ear disease. FASEB J 1996;10:1635-40.
34. Matsuoka H, Cheng K-C, Krug MS, et al. Murine model of autoimmune hearing loss induced by myelin protein PO. Ann Otol Rhinol Laryngol 1999;108:255-64.
35. Lake GM III, Sismanis A, Ariga T, et al. Antibodies to glycosphingolipid antigens in patients with immune-mediated cochleovestibular disorders. Am J Otol 1997;18:175-8.
36. Boulassel MR, Deggouj N, Tomasi JP, et al. Inner ear autoantibodies and their targets in patients with autoimmune inner ear diseases. Acta Otolaryngol 2001;121:28-34.
37. Tomasi J-P, Lona A, Deggouj N, et al. Autoimmune sensorineural hearing loss in young patients: an exploratory study. Laryngoscope 2001;111:2050-3.
38. Yamawaki M, Ariga T, Gao Y, et al. Sulfoglucuronosyl glycolipids as putative antigens for autoimmune inner ear disease. J Neuroimmunol 1998;84:111-6.
39. Ottaviani F, Cadoni G, Marinelli L, et al. Anti-endothelial autoantibodies in patients with sudden hearing loss. Laryngoscope 1999;109:1084-7.
40. Tumiati B, Casoli P. Sudden sensorineural hearing loss and anticardiolipin antibody. Am J Otolaryngol 1995;16:220.
41. Hisashi K, Komune S, Taira T, et al. Anticardiolipin antibody-induced sudden profound sensorineural hearing loss. Am J Otolaryngol 1993;4:275-7.
42. Vyse T, Luxon LM, Walport MJ. Audiovestibular manifestations of the antiphospholipid syndrome. J Laryngol Otol 1994;108:57-9.
43. Toubi E, Ben-David J, Kessel A, et al. Autoimmune aberration in sudden sensorineural hearing loss: associate with anti-cardiolipin antibodies. Lupus 1997;6:540-2.
44. Zanetti FR, Plester D, Klein R, et al. Anti-laminin antibodies in inner ear diseases: a potential marker for infectious and post-infectious processes. Arch Otolaryngol 1989;246:100-4.
45. Klein R, Timpl R, Zanetti FR, et al. High antibody levels against mouse laminin with specificity for galactosyl-(alpha 1-3)galactose in patients with inner ear diseases. Ann Otol Rhinol Laryngol 1989;98:537-42.
46. Trune DR, Kempton JB, Mitchell CM, et al. Failure of elevated heat shock protein 70 antibodies to alter cochlear function in mice. Hear Res 1998;116:65-70.
47. Billings PB, Keithley EM, Harris JP. Evidence linking the 68 kDa antigen identified in progressive sensorineural hearing loss patient sera with heat shock protein 70. Ann Otol Rhinol Laryngol 1995;104:181-8.
48. Rauch SD, Zurakowski D, Bloch DB, et al. Anti-HSP70 antibodies in Ménière's disease. Laryngoscope 2000;110:1516-21.
49. Harris JP, Woolf NK, Ryan AF. A reexamination of experimental type II collagen autoimmunity: middle and inner ear morphology and function. Ann Otol Rhinol Laryngol 1986;95:176-80.
50. Sørensen MS, Nielsen LP, Bretlau P, et al. The role of type II collagen autoimmunity in otosclerosis revisited. Acta Otolaryngol 1988;105:242-7.
51. Lopez-Gonzalez MA, Lucas M, Sanchez B, et al. Autoimmune deafness is not related to hyperreactivity to type II collagen. Acta Otolaryngol 1999;119:690-4.
52. Sutjita M, Peter JB, Baloh RW, et al. Type II collagen antibodies in patients with sensorineural hearing loss. Lancet 1992;339:559-60.
53. Satoh H. Anti-glomerular basement membrane antibody-induced inflammation in rat cochlear plexus. Acta Otolaryngol 1997;117:80-6.
54. Fattori B, Ghilardi PL, Casani A, et al. Ménière's disease: role of antibodies against basement membrane antigens. Laryngoscope 1994;104:1290-4.
55. Boulassel MR, Guérit JM, Denison S, et al. No evidence of auditory dysfunction in guinea pigs immunized with myelin PO protein. Hear Res 2001;152:10-6.
56. Kusakari C, Hozawa K, Koike S, et al. MRL/MP-lpr/lpr mouse as a model of immune-induced sensorineural hearing loss. Ann Otol Rhinol Laryngol 1992;101:82-6.
57. Ruckenstein MJ, Mount RJ, Harrison RV. The MRL-lpr/lpr mouse: a potential model of autoimmune inner ear disease. Acta Otolaryngol 1993;113:160-5.
58. Trune DR, Kempton JB, Hefeneider SH, et al. Inner ear DNA receptors in MRL/lpr autoimmune mice: potential 30 and 70 kilo-dalton link between autoimmune disease and hearing loss. Hear Res 1997;105:57-64.
59. Trune DR. Mouse models for immunologic diseases of the auditory system. In: Willott JF, ed. Handbook of Mouse Auditory Research: From Behavior to Molecular Biology. Boca Raton: CRC Press, 2001:505-31.
60. Amital H, Shoenfeld Y. Autoimmunity and autoimmune diseases such as systemic lupus erythematosus. In: Lahita RG, ed. Systemic Lupus Erythematosus. San Diego: Academic Press, 1999:1-16.
61. Lacour M, Rudolphi U, Schlesier M, et al. Type II collagen-specific human T cell lines established from healthy donors. Eur J Immunol 1990;20:931-4.
62. Soliman AM. Type II collagen-induced inner ear disease: critical evaluation of the guinea pig model. Am J Otol 1990;11:27-32.
63. Arnold WJ. Oto-immunology. Facts or fantasy? In: Veldman JE, ed. Immunobiology, Histophysiology, Tumor Immunology in Otorhinolaryngology. Amsterdam: Kugler Publications, 1987:39-45.
64. del Papa N, Conforti G, Gambini D, et al. Characterization of the endothelial surface proteins recognized by anti-endothelial antibodies in primary and secondary autoimmune vasculitis. Clin Immunol Immunopathol 1994;70:211-6.
65. Direskeneli H, D'Cruz D, Khamashta MA, et al. Autoantibodies against endothelial cells, extracellular matrix, and human collagen type IV in patients with systemic vasculitis. Clin Immunol Immunopathol 1994;70:206-10.
66. Ihrcke NS, Wrenshall LE, Lindman BJ, et al. Role of heparan sulfate in immune system-blood vessel interactions. Immunol Today 1993;14:500-5.
67. Vismara A, Meroni PL, Tincani A, et al. Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus. Clin Exp Immunol 1988;74:247-53.
68. Meroni PL, D'Cruz D, Khamashta M, et al. Anti-endothelial cell antibodies: only for scientists or for clinicians too? Clin Exp Immunol 1996;104:199-202.
69. Meroni PL, Raschi E, Testoni C, et al. Antiphospholipid antibodies and the endothelium. Rheum Dis Clin 2001;27:587-602.
70. Meroni PL, Raschi E, Testoni C. Endothelium as a target for antiphospholipid antibodies and for therapeutic intervention. Autoimmunol Rev 2002;1:55-60.
71. Faaber P, Rijke TP, van de Putte LB, et al. Cross-reactivity of human and murine anti-DNA antibodies with heparan sulfate. The major glycosaminoglycan in glomerular basement membranes. J Clin Invest 1986;77:1824-30.
72. Rauch J, Tannenbaum H, Stollar BD, et al. Monoclonal anti-cardiolipin antibodies bind to DNA. Eur J Immunol 1984;14:529-34.
73. Chan TM, Frampton G, Staines NA, et al. Different mechanisms by which anti-DNA MoAbs bind to human endothelial cells and glomerular mesangial cells. Clin Exp Immunol 1992;88:68-74.
74. Eilat D. Cross-reactions of anti-DNA antibodies and the central dogma of lupus nephritis. Immunol Today 1985;6:123-7.
75. Frampton G, Hobby P, Morgan A, et al. A role for DNA in anti-DNA antibodies binding to endothelial cells. J Autoimmunol 1991;4:463-78.
76. del Papa N, Sheng YH, Raschi E, et al. Human β2-glycoprotein I binds to endothelial cells through a cluster of lysine residues that are critical for anionic phospholipid binding and offers epitopes for anti-β2-glycoprotein I antibodies. J Immunol 1998;160:5572-8.
77. Buchanan RRC, Wardlaw JR, Riglar AG, et al. Antiphospholipid antibodies in the connective tissue diseases: their relation to the antiphospholipid syndrome and Forme Fruste disease. J Rheumatol 1989;16:757-61.
78. Manoussakis MN, Gharavi AE, Drosos AA, et al. Anticardiolipin antibodies in unselected autoimmune rheumatic disease patients. Clin Immunol Immunopathol 1987;44:297-307.
79. Sabbaga J, Line SRP, Potocnjak P, et al. A murine nephritogenic monoclonal anti-DNA autoantibody binds directly to mouse laminin, the major non-collagenous protein component of the glomerular basement membrane. Eur J Immunol 1989;19:137-43.
80. Migliorini P, Pratesi F, Bongiorni F, et al. The targets of nephritogenic antibodies in systemic autoimmune disorders. Autoimmunol Rev 2002;1:168-73.
81. Ihrcke NS, Platt JL. Shedding of heparan sulfate proteoglycan by stimulated endothelial cells: evidence for proteolysis of cell-surface molecules. J Cell Physiol 1996;168:625-37.
82. Ofosu-Appiah W, Sfeir G, Viti D, et al. Induction of systemic lupus erythematosus-like disease in mice by immunization with heparan sulfate. Cell Immunol 1998;183:22-31.
83. Krause I, Blank M, Shoenfeld Y. Anti-DNA and antiphospholipid antibodies in IVIG preparations: in vivo study in naive mice. J Clin Immunol 1998;18:52-60.
84. Tsuprun V, Santi P. Proteoglycan arrays in the cochlear basement membrane. Hear Res 2001;157:65-76.
85. Cosgrove D, Samuelson G, Pinnt J. Immunohistochemical localization of basement membrane collagens and associated proteins in the murine cochlea. Hear Res 1996;97:54-65.
86. Rodgers KD, Barritt L, Miner JH, et al. The laminins in the murine inner ear: developmental transitions and expression in cochlear basement membranes. Hear Res 2001;158:39-50.
87. Torihara K, Morimitsu T, Suganuma T. Anionic sites on Reissner's membrane, stria vascularis, and spiral prominence. J Histochem Cytochem 1995;43:299-305.
88. Yamasoba T, Suzuki M, Kaga K. Influence of chronic kanamycin administration on basement membrane anionic sites in the labyrinth. Hear Res 1996;102:116-24.
89. Tomoda K, Yamawaki T, Suzuka Y, et al. Alterations of charge barrier in the inner ear following immune reactions. Ann Otol Rhinol Laryngol 1992;Suppl 157:63-6.
90. Platt JL, Vercellotti GM, Lindman BJ, et al. Release of heparan sulfate from endothelial cells. J Exp Med 1990;171:1363-8.
91. Key NS, Platt JL, Vercellotti GM. Vascular endothelial cell proteoglycans are susceptible to cleavage by neutrophils. Arterioscler Thromb 1992;12:836-42.
92. Gharavi AE, Pierangeli SS, Harris EN. Origin of antiphospholipid antibodies. Rheum Dis Clin North Am 2001;27:551-63.